Finasteride recall: CGMP Deviations
Finasteride, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0733-90; Packaged and Distributed By: Direct Rx
Why was Finasteride recalled?
cGMP deviations
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot, expiry: 19AU2205, exp 12/31/24; 12OC2211, exp 12/31/24
- Product
- Finasteride, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0733-90; Packaged and Distributed By: Direct Rx
- Recalling firm
- Direct Rx
- Quantity
- 19 bottles
- Distribution
- Nationwide in the USA
- Recall date
- April 5, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)